CLINICAL ASPECTS OF BLOOD PRESSURE CRISIS DUE TO WITHDRAWAL OF CENTRALLY ACTING ANTIHYPERTENSIVE DRUGS
暂无分享,去创建一个
[1] P. Timmermans,et al. Cardiovascular effects of withdrawal of some centrally acting antihypertensive drugs in the rat , 1983 .
[2] R. Anderson,et al. Withdrawal syndromes and the cessation of antihypertensive therapy. , 1981, Archives of internal medicine.
[3] P. Timmermans,et al. Morphine suppresses the blood pressure responses to clonidine withdrawal in the spontaneously hypertensive rat. , 1981, European journal of pharmacology.
[4] L. Gerlis,et al. Abrupt withdrawal of the antihypertensive agent tiamenidine after 12-months' treatment. , 1980, Pharmatherapeutica.
[5] P. Boer,et al. Clonidine withdrawal. Mechanism and frequency of rebound hypertension. , 1979, British journal of clinical pharmacology.
[6] T. Whitsett,et al. Abrupt cessation of clonidine administration: a prospective study. , 1978, The American journal of cardiology.
[7] C. Dollery,et al. CLONIDINE WITHDRAWAL IN HYPERTENSION Changes in Blood-pressure and Plasma and Urinary Noradrenaline , 1977, The Lancet.
[8] S. Hoobler,et al. Central nervous system actions of clonidine in hypertension. , 1977, Mayo Clinic proceedings.
[9] E. Raftery,et al. Blood pressure and heart rate and withdrawal of antihypertensive drugs. , 1977, British medical journal.
[10] J. Petrie,et al. WITHDRAWAL OF ANTIHYPERTENSIVE THERAPY , 1974 .
[11] S. Julius,et al. Blood pressure crisis following withdrawal of clonidine (Catapres, Catapresan), with special reference to arterial and urinary catecholamine levels, and suggestions for acute management. , 1973, American heart journal.
[12] W. Mroczek,et al. Prolonged treatment with clonidine: comparative antihypertensive effects alone and with a diuretic agent. , 1972, The American journal of cardiology.
[13] S. Hoobler,et al. Clonidine hydrochloride in the treatment of hypertension. , 1971, The American journal of cardiology.
[14] H. Hedeland,et al. Studies on catecholamines, renin and aldosterone following Catapresan (2-(2,6-dichlor-phenylamine)-2-imidazoline hydrochloride) in hypertensive patients. , 1970, European journal of pharmacology.